Skip to Content

Aspiriant Risk-Managed Equity Allc Adv RMEAX Fund Analysis

| Medalist Rating as of | See Aspiriant Investment Hub

Morningstar’s Analysis RMEAX

Will RMEAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit Aspiriant Risk-Managed Equity Allc Adv to a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor